150 related articles for article (PubMed ID: 27063390)
1. Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.
Laigre E; Hazelard D; Casas J; Serra-Vinardell J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Compain P
Carbohydr Res; 2016 Jun; 429():98-104. PubMed ID: 27063390
[TBL] [Abstract][Full Text] [Related]
2. A systematic investigation of iminosugar click clusters as pharmacological chaperones for the treatment of Gaucher disease.
Joosten A; Decroocq C; de Sousa J; Schneider JP; Etamé E; Bodlenner A; Butters TD; Compain P
Chembiochem; 2014 Jan; 15(2):309-19. PubMed ID: 24375964
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
Wang GN; Twigg G; Butters TD; Zhang S; Zhang L; Zhang LH; Ye XS
Org Biomol Chem; 2012 Apr; 10(15):2923-7. PubMed ID: 22286559
[TBL] [Abstract][Full Text] [Related]
4. Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
Sánchez-Ollé G; Duque J; Egido-Gabás M; Casas J; Lluch M; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2009; 42(2):159-66. PubMed ID: 19167250
[TBL] [Abstract][Full Text] [Related]
5. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
[TBL] [Abstract][Full Text] [Related]
6. Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease.
Borie-Guichot M; Lan Tran M; Garcia V; Oukhrib A; Rodriguez F; Turrin CO; Levade T; Génisson Y; Ballereau S; Dehoux C
Bioorg Chem; 2024 May; 146():107295. PubMed ID: 38513326
[TBL] [Abstract][Full Text] [Related]
7. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.
Parmeggiani C; Catarzi S; Matassini C; D'Adamio G; Morrone A; Goti A; Paoli P; Cardona F
Chembiochem; 2015 Sep; 16(14):2054-64. PubMed ID: 26376302
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
Wang GN; Reinkensmeier G; Zhang SW; Zhou J; Zhang LR; Zhang LH; Butters TD; Ye XS
J Med Chem; 2009 May; 52(10):3146-9. PubMed ID: 19397268
[TBL] [Abstract][Full Text] [Related]
9. Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease.
Kato A; Nakagome I; Sato K; Yamamoto A; Adachi I; Nash RJ; Fleet GW; Natori Y; Watanabe Y; Imahori T; Yoshimura Y; Takahata H; Hirono S
Org Biomol Chem; 2016 Jan; 14(3):1039-48. PubMed ID: 26633162
[TBL] [Abstract][Full Text] [Related]
10. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem, a L-type Ca(2+) channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells.
Rigat B; Mahuran D
Mol Genet Metab; 2009 Apr; 96(4):225-32. PubMed ID: 19167257
[TBL] [Abstract][Full Text] [Related]
13. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
Trapero A; Llebaria A
Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
[TBL] [Abstract][Full Text] [Related]
14. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
[TBL] [Abstract][Full Text] [Related]
15. Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease.
Goddard-Borger ED; Tropak MB; Yonekawa S; Tysoe C; Mahuran DJ; Withers SG
J Med Chem; 2012 Mar; 55(6):2737-45. PubMed ID: 22360565
[TBL] [Abstract][Full Text] [Related]
16. Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.
Yu Z; Sawkar AR; Whalen LJ; Wong CH; Kelly JW
J Med Chem; 2007 Jan; 50(1):94-100. PubMed ID: 17201413
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
Mena-Barragán T; García-Moreno MI; Nanba E; Higaki K; Concia AL; Clapés P; García Fernández JM; Ortiz Mellet C
Eur J Med Chem; 2016 Oct; 121():880-891. PubMed ID: 26361824
[TBL] [Abstract][Full Text] [Related]
18. Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry.
Tropak MB; Kornhaber GJ; Rigat BA; Maegawa GH; Buttner JD; Blanchard JE; Murphy C; Tuske SJ; Coales SJ; Hamuro Y; Brown ED; Mahuran DJ
Chembiochem; 2008 Nov; 9(16):2650-62. PubMed ID: 18972510
[TBL] [Abstract][Full Text] [Related]
19. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
Mena-Barragán T; García-Moreno MI; Sevšek A; Okazaki T; Nanba E; Higaki K; Martin NI; Pieters RJ; Fernández JMG; Mellet CO
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673163
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
Diot JD; Garcia Moreno I; Twigg G; Ortiz Mellet C; Haupt K; Butters TD; Kovensky J; Gouin SG
J Org Chem; 2011 Oct; 76(19):7757-68. PubMed ID: 21830816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
